3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
6
Colorectal Neoplasms
6
Breast Neoplasms
6
Neoplasms
5
Lung Neoplasms
4
Prostatic Neoplasms
2
Papillomavirus Infections
2
End Stage Liver Disease
2
Warts
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Tinea
1
Smoking
1
Skin Neoplasms
1
Nevus
1
Neoplasm Metastasis
1
Multiple Endocrine Neoplasia Type 1
1
Molluscum Contagiosum
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lung Cancer Screening
1
Liver Neoplasms
1
Kidney Failure, Chronic
1
Keratosis, Actinic
1
Intestinal Neoplasms
1
Impetigo
1
Herpes Zoster
1
Hepatitis C
1
HIV Infections
1
Gastrointestinal Neoplasms
1
Interventions
Zidovudine
3
Methotrexate
2
Leucovorin
2
Dexamethasone
2
fludarabine phosphate
1
X-Rays
1
Whole-Body Irradiation
1
Vincristine
1
Triage
1
Transurethral Resection of Prostate
1
Therapeutics
1
Tetanus Toxoid
1
Standard of Care
1
Smoking Devices
1
Semaxinib
1
Practice Guidelines as Topic
1
Pneumococcal Vaccines
1
Peripheral Blood Stem Cell Transplantation
1
Papillomavirus Vaccines
1
Papanicolaou Test
1
Mycophenolic Acid
1
Measles-Mumps-Rubella Vaccine
1
Massage
1
Mass Screening
1
Inosine Pranobex
1
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
Heptavalent Pneumococcal Conjugate Vaccine
1
Hepatitis B Vaccines
1
Health Promotion
1
Etanercept
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
HIV Infections
×
Mass Screening
×
Clear all
NCT07225530
2026-02-25
(iSTAR)
Columbia University
Phase NA
Recruiting
600 enrolled